Sort
17,828 grants matching “crispr”
The Role of GATA3 and SATB2 in Early Colonic Patterning
$377,500Jorge O Munera · Medical University Of South Carolina · R56 · FY2022 · DK
Administrative Core
$377,454Arlene H Sharpe · Harvard Medical School · U19 · FY2021 · AI
Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
$377,438Woojin An · University Of Southern California · R01 · FY2020 · CA
Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
$377,438Woojin An · University Of Southern California · R01 · FY2016 · CA
Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
$377,438Woojin An · University Of Southern California · R01 · FY2017 · CA
Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
$377,438Woojin An · University Of Southern California · R01 · FY2018 · CA
Project 3 - Mapping Long-range Allosteric Pathways in CRISPR-Cas9
$377,377George Lisi · Brown University · P20 · FY2021 · GM
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease
$377,363James J Galligan · University Of Arizona · R35 · FY2023 · GM
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease
$377,363James J Galligan · University Of Arizona · R35 · FY2024 · GM
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease
$377,363James J Galligan · University Of Arizona · R35 · FY2020 · GM
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease
$377,363James J Galligan · University Of Arizona · R35 · FY2022 · GM
Establishing Glyoxalase 2 as a Viable Target for the Treatment of Disease
$377,363James J Galligan · University Of Arizona · R35 · FY2021 · GM
Advancing CRISPR-Cas Technologies for the Discovery and Characterization of Novel Fungal Natural Products
$377,328Xue Gao · Rice University · R35 · FY2021 · GM
Advancing CRISPR-Cas Technologies for the Discovery and Characterization of Novel Fungal Natural Products
$377,328Xue Gao · Rice University · R35 · FY2022 · GM
Advancing CRISPR-Cas Technologies for the Discovery and Characterization of Novel Fungal Natural Products
$377,328Xue Gao · Rice University · R35 · FY2020 · GM
Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
$377,305Abby R Kroken · Loyola University Chicago · R01 · FY2022 · EY
Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
$377,305Abby R Kroken · Loyola University Chicago · R01 · FY2024 · EY
Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
$377,305Abby R Kroken · Loyola University Chicago · R01 · FY2025 · EY
Inflammasome-mediated corneal epithelial cell defenses inhibited by pathogenic bacteria
$377,305Abby R Kroken · Loyola University Chicago · R01 · FY2023 · EY
Retinal Muller Glial Cells in the initiation of diabetic retinopathy
$377,255Sui Wang · Stanford University · R01 · FY2023 · EY
MSCS ENGINEERED TO PRODUCE BDNF AND GENE EDITING CARGO FOR THE TREATMENT OF HUNTINGTON'S DISEASE
$377,253Kyle Fink · University Of California At Davis · R01 · FY2024 · NS
Progression, response, and resistance of RSPO fusion colorectal cancer
$377,180Lukas Edward Dow · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Project 3: A New Therapeutic Target for TERT Promoter Mutant Glioma
$377,107Joseph F Costello · University Of California, San Francisco · P50 · FY2018 · CA
Molecular basis of tumor suppression by Cdk4/6 inhibition
$377,097Seth Michael Rubin · University Of California Santa Cruz · R01 · FY2019 · CA
Role of p53 Missense Mutations on Tumorigenesis in Vivo
$377,055Guillermina Lozano · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA